Crossmark

Revisiting Flubendazole Through Nanocrystal Technology: Statistical Design, Characterization and Its Potential Inhibitory Effect on Xenografted Lung Tumor Progression in Mice

Crossref DOI link: https://doi.org/10.1007/s10876-022-02220-x

Published Online: 2022-01-14

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

de Souza Gonçalves, Débora

Yukuyama, Megumi Nishitani

Miyagi, Mariana Yasue Saito

Silva, Tâmara Juliane Vieira

Lameu, Claudiana

Bou-Chacra, Nadia Araci

de Araujo, Gabriel Lima Barros
Funding

Funding for this research was provided by:

Fundação de Amparo à Pesquisa do Estado de São Paulo (15/19128-2, 2018/22713-2, 2019/04998-2)
License Information

Text and Data Mining valid from 2022-01-14

Version of Record valid from 2022-01-14
More Information

Article History

Received: 27 September 2021

Accepted: 7 December 2021

First Online: 14 January 2022

Document is current

Any future updates will be listed below